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Abstract
Purpose of Review There is growing interest in the relation-
ship between anorexia nervosa (AN) and autism spectrum
disorder (ASD). This review aimed to synthesise the most
recent research on this topic to identify gaps in current knowl-
edge, directions for future research and reflect on implications
for treatment.
Recent Findings Eight studies assessing the presence of ASD
in AN were identified in the literature along with three studies
examining the impact of symptoms of ASD on treatment out-
come. Research with young people and using parental-report
measures suggest lower rates of co-morbidity than previous
adult studies.
Conclusions The wide range of diagnostic tools, methodolo-
gies and populations studied make it difficult to determine the
prevalence of ASD in AN. Despite this, studies consistently
report over-representation of symptoms of ASD in AN. Co-
morbid AN and ASDmay require more intensive treatment or
specifically tailored interventions. Future longitudinal re-
search and female-specific diagnostic tools would help eluci-
date the relationship between these two disorders.
Keywords Anorexia nervosa . Autism spectrum disorder .
Systematic review . Eating disorder . Female ASD
Introduction
Anorexia nervosa (AN) is a severe eating disorder (ED)
characterised by low body weight, intense fear or gaining
weight and undue influence of weight and shape on self-
evaluation [1]. It tends to manifest during adolescence [2] and
has the highest mortality rate of any psychiatric disorder, with
no gold standard treatment [3], high treatment dropout and re-
lapse rates. In contrast, autism spectrum disorder (ASD) is a
pervasivedevelopmentaldisorderwithmarkeddifficultieswith
social interaction and communication and repetitive, stereo-
typed interests and behaviours (APA, 2013). For ASD to be
diagnosed, symptoms must be present during infancy. While
both AN and ASD are rare disorders within the general popu-
lation, affecting around0.3 and 1%, respectively [4, 5], they are
associated with opposite gender ratios. AN is reported to be up
to ten timesmoreprevalent in femaleswhile the reportedgender
ratio for ASD is four males to one female [6]. Interestingly, in
non-referredsamples, thereareonly twotothreemales forevery
female with ASD [7] suggesting that many females are not
referred and thus never receive a diagnosis [8].
Interest in the potential link between the two disorders be-
gan with suggestion that a shared underlying genetic vulnera-
bility may interact with environmental factors to manifest as
AN in girls during adolescence and ASD in boys during in-
fancy [9]. Since then, growing research has attempted to elu-
cidate the nature of the relationship between the two disorders,
focusing on both elevated presence of ASD in AN and shared
underlying difficulties in cognitive, social and emotional func-
tioning [10–13].
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Two previous reviews have examined the prevalence of
ASD or elevated ASD symptoms in AN [14, 15]. Huke and
colleagues [14] investigated the prevalence of ASD in ED
populations, synthesising studies which used a variety of dif-
ferent diagnostic tools. The mean estimated prevalence of
ASD from Huke and colleagues [14] review was 23%, sug-
gesting an over-representation of ASD in EDs. However, six
of the eight studies in Huke and colleagues’ review were
based on longitudinal research with the same, Swedish com-
munity cohort [16–21]. Despite the diagnostic criteria for
ASD requiring symptoms to be present during the early de-
velopmental period, the prevalence of estimated ASD ranged
from 8 to 37% during the course of this longitudinal research,
which used different diagnostic tools at each follow-up. This
suggests that different assessment methods along with chang-
ing diagnostic criteria, e.g. the update from DSM-III-R to
DSM-5 leads to unstable levels of reported ASD in AN pop-
ulations. This review did not include studies with young peo-
ple and concluded that studies from different cohorts were
needed. Westwood and colleagues [15] conducted a system-
atic review and meta-analysis of studies using the self-report
autism spectrum quotient AQ; [22] or abbreviated, ten-item
version AQ-10; [23] to assess ASD symptoms in AN.
Individuals with AN were found to have significantly more
difficulties associated with ASD than healthy controls.
Despite the potential benefits of accurately assessing the
prevalence of ASD in AN, doing so is challenging. Missed
or delayed diagnosis of ASD in females during childhood
could leave them vulnerable to the development of secondary
mental health problems [24] including AN, which may ob-
scure the identification of ASD when manifested as extreme
rigidity or obsessive interest in calories or exercise [25]. The
nature of the relationship between AN and ASD is complicat-
ed further by the possibility that some individuals without
ASD may come to exhibit behaviours associated with the
disorder during the acute phase of AN [26]. This trait versus
state conundrum, along with the variety of different diagnostic
criteria used and heterogeneous groups assessed makes it dif-
ficult to draw conclusions on whether ASD really is over-
represented in AN, relative to the general population or other
psychiatric disorders.
The aim of this review is to synthesise the current literature
on the relationship between ASD and AN, including studies
with young people and research examining the potential im-
pact of ASD on treatment outcome. While there is growing
evidence of similarities between the two disorders in terms of
cognitive and socioemotional processing [12, 11, 13], studies
focusing purely on such similarities are outside the scope of
this review. While some studies have examined ASD across
the spectrum of EDs, the majority have focused on its preva-
lence within AN. Therefore, only studies with participants
with a diagnosis of AN are included, although where studies
include more than one patient group, e.g. AN and bulimia
nervosa (BN), this is stated. As self-report measures such as
the AQ are limited to the assessment of current symptoms
rather than accounting for any developmental history of
ASD and rely on the subjective insights of the responder,
which may be confounded by the acute phase of AN, studies
which are based entirely on self-report questionnaires have
been excluded from this review.
Review of the Literature
Studies Using Diagnostic Assessment Tools
Diagnostic guidelines for ASD [27] recommend using both
developmental and observational assessment tools. This has
led to studies assessing for ASD in AN using standardised
diagnostic or screening tools including the Autism
Diagnostic Observation Schedule, 2nd Edition ADOS-2;
[28]; the Development and Well-being Assessment
DAWBA; [29] and the Developmental, Dimensional and
Diagnostic Interview 3Di; [30]. The ADOS-2 is a semi-
structured assessment for ASD and is the most widely-used
and best validated direct observational measure of character-
istics associated with ASD [27]. The DAWBA is a self and
informant-report screening measure, designed to generate
DSM psychiatric diagnoses for children and adolescents.
The 3Di is a validated parental report, diagnostic measure of
ASD. It demonstrates good sensitivity with confirmed clinical
diagnosis for DSM-5 [31]. Eight studies assessing ASD in ED
populations using various clinical assessment tools were iden-
tified in the literature since the publication of Huke and col-
leagues’ review [14] and are summarised in Table 1.
Studies with Adults
A small case series conducted by Mandy, Tchanturia [32]
aimed to assess the feasibility of using the ADOS with an
ED population. The study recruited a pre-selected sample of
women EDs who had suspected ASD due to exhibiting social
and flexibility difficulties and who did not respond to standard
ED treatment protocols. Half of the women assessed met di-
agnostic criteria on the ADOS, while a further two were
deemed likely to have ASD, despite not meeting the required
cut-off on the ADOS.While the study demonstrated the utility
of using the ADOS, the design of the study prevented conclu-
sions being drawn about the prevalence of ASD.
This pilot study was extended byWestwood and colleagues
[33•] who used the ADOS-2 to assess for ASD symptoms in a
sample of 60 women diagnosed with AN. The proportion of
participants who scored above cut-off on the ADOS-2, indi-
cating the presence of symptoms characteristic of ASD, was
the same as the mean prevalence rate (23%) reported in Huke
and colleagues’ [14] systematic review. This is the largest
41 Page 2 of 10 Curr Psychiatry Rep (2017) 19: 41
T
ab
le
1
St
ud
ie
s
us
in
g
cl
in
ic
al
as
se
ss
m
en
ts
of
A
SD
in
in
di
vi
du
al
s
w
ith
A
N
St
ud
y
N
an
d
di
ag
no
si
s
M
ea
n
(S
D
)
ag
e
A
ss
es
sm
en
tt
oo
l
R
es
ul
t
Po
on
ie
ta
l.,
(2
01
2)
E
O
E
D
=
22
T
D
co
nt
ro
ls
=
24
A
SD
co
nt
ro
ls
=
20
13
.0
(1
.6
)
13
.0
(2
.4
)
11
.6
(2
.0
)
3D
i-
sv
O
ne
(4
.5
%
)
pa
rt
ic
ip
an
tw
ith
E
O
E
D
ha
d
A
S
D
.E
le
va
te
d
le
ve
ls
of
A
SD
sy
m
pt
om
s
in
E
O
E
D
gr
ou
p.
R
hi
nd
et
al
.,
(2
01
4)
A
N
=
15
0
16
.9
(2
.1
3)
D
A
W
B
A
4%
re
ce
iv
ed
po
ss
ib
le
or
de
fi
ni
te
di
ag
no
si
s
of
A
SD
M
an
dy
&
Tc
ha
nt
ur
ia
(2
01
5)
A
N
=
7
E
D
N
O
S
=
2
B
N
=
1
26
.4
(6
.5
9)
A
D
O
S-
2
M
od
ul
e
4
50
%
(p
re
-s
el
ec
te
d
sa
m
pl
e)
sc
or
ed
ab
ov
e
cu
t-
of
f
on
A
D
O
S-
2.
V
ag
ni
et
al
.,
(2
01
6)
A
N
=
29
B
N
=
25
B
E
D
=
13
19
.8
(1
.0
)
24
.5
(1
.6
)
27
.0
(1
.9
)
R
A
A
D
S
-R
33
%
of
pa
rt
ic
ip
an
tw
er
e
cl
as
si
fi
ed
as
hi
gh
le
ve
ls
of
au
tis
tic
sy
m
pt
om
s.
B
en
tz
et
al
.,
(2
01
7)
A
N
=
43
A
N
-R
=
28
T
D
co
nt
ro
ls
=
41
16
.1
(1
.5
)
18
.4
(1
.6
)
17
.7
(2
.2
)
A
D
O
S-
2
M
od
ul
e
4
16
%
of
in
di
vi
du
al
s
w
ith
A
N
an
d
21
%
of
th
os
e
w
ith
A
N
-R
sc
or
ed
ab
ov
e
cu
t-
of
f
on
th
e
A
D
O
S-
2.
Po
st
or
in
o
et
al
.,
(2
01
7)
A
N
=
30
T
D
co
nt
ro
ls
=
35
14
.1
9
(1
.5
6)
13
.6
(1
.6
1)
A
D
O
S-
2
M
od
ul
e
3
or
4
10
%
of
in
di
vi
du
al
s
w
ith
A
N
sc
or
ed
ab
ov
e
cu
t-
of
f
on
th
e
A
D
O
S-
2.
W
es
tw
oo
d
et
al
.,
(2
01
7)
A
N
=
60
26
.3
(7
.8
)
A
D
O
S-
2
M
od
ul
e
4
23
.3
%
sc
or
ed
ab
ov
e
cu
t-
of
f
on
A
D
O
S-
2.
W
es
tw
oo
d
et
al
.,
(i
n
pr
es
s)
A
N
=
40
15
.2
(1
.5
2)
A
D
O
S-
2
M
od
ul
e
4
3D
i-
sv
52
.5
%
sc
or
ed
ab
ov
e
cu
t-
of
f
on
th
e
A
D
O
S.
2
10
%
sc
or
ed
ab
ov
e
cu
t-
of
f
on
bo
th
th
e
A
D
O
S-
2
an
d
3D
i-
sv
.
A
D
O
S-
2
au
tis
m
di
ag
no
st
ic
ob
se
rv
at
io
n
sc
he
du
le
,2
nd
ed
iti
on
,A
N
an
or
ex
ia
ne
rv
os
a,
A
N
-R
an
or
ex
ia
ne
rv
os
a,
re
st
ri
ct
iv
e
su
bt
yp
e,
A
SD
au
tis
m
sp
ec
tr
um
di
so
rd
er
,B
E
D
bi
ng
e
ea
tin
g
di
so
rd
er
,B
ul
im
ia
N
er
vo
sa
bu
lim
ia
ne
rv
os
a,
D
AW
B
A
de
ve
lo
pm
en
ta
nd
w
el
l-
be
in
g
as
se
ss
m
en
t,
E
D
N
O
S
ea
tin
g
di
so
rd
er
no
to
th
er
w
is
e
sp
ec
if
ie
d,
E
O
E
D
ea
rl
y
on
se
te
at
in
g
di
so
rd
er
,N
nu
m
be
r
of
pa
rt
ic
ip
an
ts
,R
A
A
D
S-
R
R
itv
o
au
tis
m
A
sp
er
ge
r
di
ag
no
st
ic
sc
al
e,
re
vi
se
d,
3D
i-s
v
de
ve
lo
pm
en
ta
l,
di
m
en
si
on
al
an
d
di
ag
no
st
ic
in
te
rv
ie
w
,s
ho
rt
ve
rs
io
n
Curr Psychiatry Rep (2017) 19: 41 Page 3 of 10 41
study to date to use a “gold standard” diagnostic measure of
ASD with an adult cohort of women with AN. Despite this,
information on the developmental history of the participants
was not obtained so conclusions regarding the aetiology of the
symptoms, i.e. whether ASD was present prior to the onset of
the disorder, could not be drawn. Elevated ASD symptoms
were also associated with increased obsessive-compulsive
symptoms and alexithymia. The presence of other co-morbid
symptoms such as these could mediate the relationship be-
tween AN and apparent ASD. Alternatively, they could sug-
gest that individuals with both AN and ASD are more likely to
experience additional mental health problems.
To assess the heterogeneity of ASD symptoms in EDs,
Vagni and colleagues [42] routinely screened all new outpa-
tients, aged 15 and or over, admitted to a specialist ED ward
using the Ritvo Autism Asperger Diagnostic Scale Revised
RAADS-R; [43]. The aim of the study was to find a tool able
to discriminate between individuals with high and low levels
of autistic symptoms and to assess their relative prevalence.
The RAADS-R was used as a clinical, structured interview
and was chosen instead of the ADOS as the latter has been
criticised for its ability to discriminate between adults with co-
morbidities with no previous ASD diagnosis [44••] and re-
quires extensive and specific training. Using this measure,
33% of individuals were classified as having elevated ASD
symptoms. However, as the RAADS-R still relies on the sub-
jective insights of the interviewee and no attempt to ascertain
developmental history from relatives was made, it is not pos-
sible to determine with certainty whether any ASD symptoms
predated the onset of the ED.
Studies with Young People
To control for the impact that starvation and duration of AN
may have on the presence of ASD symptoms, recently pub-
lished studies have recruited younger people with either early
onset EDs or individuals with short illness durations. To in-
vestigate whether scores on the ADOS-2 are corroborated by
parental report, Westwood and colleagues [34••] assessed a
sample (n = 40) of adolescent females, aged 12 to 18.
Twenty-one (52.5%) scored at or above cut-off on the
ADOS-2 so their parents were asked to complete the 3Di,
short version 3Di-sv; [35], a well-validated measure of ASD
which provides categorical diagnoses as well as measuring
dimensionally-occurring ASD symptoms across both clinical
and typically developing populations. Only 4 (10%) individ-
uals scored above cut-off on both the ADOS-2 and 3Di-sv,
thus meeting research criteria for ASD. These results suggest
that while a significant proportion of young people present
with symptoms associated with ASD, these symptoms were
not present during the early developmental period, a require-
ment for ASD diagnosis. Alternatively, it could be that such
symptoms are not recognised by parents during infancy. Other
studies conducted with young people with AN have reported
similar findings when using parental-report measures [36, 37].
Pooni and colleagues [36] attempted to address the issue of
separating the presence of current ASD symptoms and a de-
velopmental history of ASD in individuals with early onset
ED (EOED).While EOED is difficult to define [38], the study
adopted criteria operationalised by Nicholls and colleagues
[39] including: weight loss or failure to gain weight; fear of
weight gain and preoccupation with gaining weight. When
ICD-10 criteria were used, 20 of the 22 participants were
assigned a diagnosis of AN or atypical AN. Using the 3Di,
Pooni and colleagues [36] found that a diagnosis of ASD was
no more likely in individuals with EOED than in typically
developing controls. However, the EOED group did exhibit
elevated levels of ASD symptoms. A similar finding was re-
ported by Rhind and colleagues [37] who used the DAWBA.
Only 4% of female participants were assigned a possible di-
agnosis of ASD while up to 39% of participants showed dif-
ficulties with social aptitude and peer relationships.
Twoother studieswith youngpeople haveutilised theADOS-
2 to assess the presence of observable symptoms associated with
ASD. Postorino and colleagues [40•] assessed a group of female
adolescents (N = 30), diagnosed with AN during the acute phase
of illness. Contrary to Westwood and colleague’s findings, only
10% scored above cut-off on the ADOS-2.While a standardised
developmental measure such as the 3Di was not used, according
to a clinical interview, no participant was given a diagnosis of
ASD.Theother study [41••] aimed tocompare social functioning
in participants with first-episode, recent onset (within 12 months
of participating) AN with those recovered from the disorder.
Despite a previous diagnosis of ASD being ruled out, 16 and
21% of individuals respectively scored above cut-off on the
ADOS-2. Similar levels of functional impairment between the
two groups suggest that social difficulties are not limited to the
acute phase of the illness. As the study did not investigate the
developmental history of these difficulties, the findingswere lim-
ited to examination of social difficulties rather than ASD per se.
The limited evidence available from studies with young peo-
plesuggests thatdespite individualswhoarecurrently illwithAN
displaying high levels of symptoms characteristic of ASD, the
history of these symptoms is not corroborated by parental report.
There are several possible reasons for this, including but not
limited to: (1) such symptoms are an epiphenomenon, arising
from the ill-state associated with AN; (2) parents under-report
or do not recognise the behaviour of their child as being associ-
atedwithASD,particularly ingirls, asASDisoftenconsidered to
be a “male disorder”; (3) The diagnostic tools being used are not
sensitive todetectingASDsymptoms inapredominantly female,
AN population. Pooni and colleagues [36] also suggest that the
developmental trajectory ofEDs into adulthoodmay account for
someof thediscrepancy inASDprevalencebetweenyoungpeo-
ple andadults. Theprognosis of adolescent onsetEDs is relative-
ly good [42] but individuals who do not recover will likely be
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seen in adult services. The presence of ASD or elevated ASD
symptoms may therefore be a predictor of poorer treatment out-
come, leading to its relative over-representation in adult services.
Nationwide Cohort Study
Onestudy[43]aimedto investigate theco-morbidityofASDand
AN and familial aggregation of the disorders by using Danish
registers to identify individuals classified as havingAN, atypical
AN, infantile autism, atypical autismorAsperger syndromewho
hadrecords foreither inpatientoroutpatientcare for thatdisorder.
Tostudy familial aggregationof thedisorders,probandsand their
parentsandsiblingsdiagnosedwithEDs,ASD,majordepression
oranypsychiatricdisorderswere included.Five thousandandsix
individuals with AN and 12,606 with ASD were identified
through screening. Probands with a primary diagnosis of AN
had a highly elevated risk of receiving a diagnosis of ASD, with
the risk for males being higher than for females. However, there
was an evenhigher risk of being diagnosedwithASD in individ-
uals whose primary diagnosis was major depression. A family
history of AN was associated with an elevated risk of ASD but
this riskwas comparable to that seen in familieswith a history of
major depressionandanypsychiatricdisorder.This suggests that
while there is increased risk of co-morbidity ofANandASDand
aggregation of ASD in families with AN, the relationship be-
tween the twodisorders isnon-specific.Thus,ASDmayincrease
the likelihood of receiving any psychiatric diagnosis but not spe-
cifically a diagnosis of AN.
Summary of Literature Review
There is consistent evidence, using a variety of assessment
tools, that symptoms associated with ASD are over-
represented in EDs, particularly in AN. Studies report between
4 and 52.5% of participants meeting suggested clinical cut-off
for ASD. Despite this, research utilising parental reports to
determine the presence of such symptoms during early child-
hood report much lower rates [36, 37, 34••] of participants
meeting clinical cut-off. While the aetiology of these symp-
toms remaining unclear, three further studies have examined
the potential impact of ASD symptoms on treatment outcome
in AN. These studies are discussed in the next section of this
review.
Impact of ASD Symptoms on Treatment Outcome
To date, three studies, displayed in Table 2, have attempted to
examine the potential impact of ASD symptoms on treatment
outcome in ED groups using clinical measures of ASD.
The largest study [44••] used clinical audit data to examine
the impact of ASD symptoms on treatment outcome in girls
referred to a specialist ED service. Again, the presence of
current ASD symptoms was elevated in this cohort but there
was no evidence of raised prevalence of childhood ASD, as
measured by the DAWBA. Girls with elevated ASD symp-
toms, as measured by the AQ required greater augmentation
of treatment reflected in admission to an intensive day treat-
ment programme or inpatient wards. Scores on the Social
Aptitude Scale SAS; [45], a parental-rated measure of a young
person’s social skills, were not related to treatment augmenta-
tion. Less change in the self-report EDE-Q subscale scores of
weight concern, shape concern and global score was also as-
sociated with higher DAWBA ASD scores.
In the fourth follow-up of the longitudinal Swedish cohort
study described in the introduction to this review, Nielsen and
colleagues [46] examined the effect of ASD on outcome using
the Morgan-Russell outcome assessment schedule MROAS;
[47]. The cohort were initially assessed at age 16 then again at
6-year, 10-year and 16-year follow-ups. The tools used to
diagnose ASD differed across all four studies, consisting of
the following: study (1) structured interview with mother;
study (2) Dewey social awareness test, checklist for autistic
disorder and Asperger’s syndrome; study (3) Asperger
Syndrome Diagnostic Interview, checklist for autistic disorder
and Asperger’s syndrome and study (4) Asperger Syndrome
Diagnostic Interview, checklist for autistic disorder and
Asperger’s syndrome and the AQ. Six AN participants were
classified having ASD at all four assessment points. The
MROAS is a structured interview, concerned with the clinical
features of AN. Responses to questions about eating, weight,
mental state and attitudes yield five sub-scores, used to mon-
itor change in clinical status [48]. The presence of ASD con-
tributed to restricted outcomes in mental, psychosexual and
socio-economic state, as measured by the MROAS: the more
diagnostic stability of ASD, the worse the outcome.
The impact of symptoms associated with ASD on specific
treatment outcome has been examined by Tchanturia and col-
leagues [49] in relation to group Cognitive Remediation
Therapy (CRT). In this cohort study, ASD was assessed with
at least one of the following: ADOS-2, AQ or AQ-10 depend-
ing on whether a trained researcher was available to adminis-
ter the ADOS-2 to at the time of admission. Fourteen (40%)
participants scored above cut-off on at least one measure, sug-
gesting the presence of elevated ASD symptoms. The Detail
and Flexibility Questionnaire [50] was used to assess self-
reported changes in cognitive rigidity and attention to detail.
Whereas the low-scoring group showed significant improve-
ment in cognitive rigidity and self-reported ability to change
following the group CRT intervention, the high-scored ASD
group showed no improvements on any outcome measure.
While other co-morbidities such as anxiety and depression
were not accounted for, this data suggests that elevated ASD
symptoms may be associated with poorer response to existing
ED treatments, specifically targeted at improving difficulties
with flexibility, associated with ASD [11].
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Assessment of ED Symptoms in ASD
Despite numerous studies exploring the presence of ASD in
AN populations, little research has examined the opposite
phenomenon, i.e. EDs in people with ASD. While there is
scientific consensus supporting an association between ASD
and food selectivity [51], the latter includes food refusal, lim-
ited repertoire of foods and is thus not necessarily associated
with ED psychopathology. There have been case reports of
girls with an underlying diagnosis of Asperger syndrome
exhibiting symptoms of AN [52–54], emphasising the impor-
tance of diagnosing AN in individuals in ASD so that appro-
priate treatment can be sought. The inclusion of Avoidant and
Restrictive Food Intake Disorder (ARFID) in DSM-5 [1],
characterised by limited consumption of food due to its sen-
sory characteristics or past negative experiences with food,
has led to research into the presence of ARFID in ASD [55].
There is also evidence that ARFID is common in young peo-
ple with eating disorders. One study found that 22.5% of
young people attending a day treatment programme for EDs
met ARFID criteria [56]. Higher rates of co-morbid anxiety
disorders, learning disabilities and pervasive developmental
disorders (including ASD) were found in the ARFID group,
compared to those with AN, BN or OSFED.
Gillberg [57] recently coined the term ESSENCE (Early
Symptomatic Syndromes Eliciting Neurodevelopmental
Clinical Examinations) to cover neurodevelopmental disor-
ders such as ASD and Attention Deficit Hyperactivity
Disorder (ADHD) which often co-occur and lead to children
presenting in clinical settings with difficulties in several do-
mains of functioning. One study [58] aimed to examine the
prevalence of EDs and eating pathology in a sample of 228
young adults and adults with ESSENCE. Within the entire
sample, 7.9% had a current or previous ED but individuals
with a diagnosis of ADHDmore often affirmed eating pathol-
ogy than individuals with ASD. This study suggests that EDs
may be over-represented in individuals with neuropsychiatric
disorders but not specifically ASD. Interestingly, the gender
ratio in this study was not as skewed (1:2.5 male: female) as in
the general population, with a large proportion of men
experiencing EDs or reporting ED pathology.
Future Directions and Clinical Implications
Diagnosing ASD in individuals with AN is a complex process
which requires thorough clinical assessment including direct
observation of symptoms and comprehensive developmental
history. While attempts have been made to elucidate the rela-
tionship between ASD in AN, the presence of other co-mor-
bidities, varying diagnostic tools and criteria, and the possibil-
ity of a distinct female autism phenotype make it difficult to
draw firm conclusions about the true prevalence of ASD in
AN. Recent studies have utilised developmental measures and
recruited younger participants in an attempt to control for the
impact that ED pathology may have on ASD symptoms.
Despite this, studies have used different cut-off points to de-
fine elevated symptoms or assessment tools which may not be
sensitive enough to distinguish ASD in females or differenti-
ate between ASD and other co-morbidities.
Despite growing evidence that ASD presents differently in
females than in males (e.g. [59]), standard diagnostic tools
such as the ADOS-2 and Autism Diagnostic Interview-
Revised, ADI-R; [60] and DSM-5 diagnostic criteria [1] have
not reflected on these gender differences. As most diagnostic
tools are validated with males, females are less likely to pres-
ent with symptoms detected with such tools, leading to an
underestimation of ASD in females [61]. Until routine assess-
ment tools recognise and reflect the gender differences in
ASD, diagnosing ASD in individuals with AN, who are not
only predominantly female but who often present with a mul-
titude of co-morbidities, will remain problematic. Future re-
search focusing on the development of gender-specific diag-
nostic algorithms and screening tools is urgently needed.
Once gender-sensitive diagnostic tools have been
established, further research utilising a longitudinal design
and following stringent diagnostic criteria will be needed to
fully understand the relationship between the two disorders.
To determine whether undiagnosed ASD really does leave
females at increased risk of developing AN, it would also be
beneficial to identify “high risk” cases, e.g. sisters of individ-
uals with ASD or young females with a diagnosis of high-
functioning ASD and to assess for eating disorder psychopa-
thology. To date, research has not focused on the lived-
experience of individuals with both AN and ASD. If, as pre-
viously hypothesised [25], ASD can manifest as extreme ri-
gidity or interest in calories, exercise or food, it may be that the
ED pathology of individuals with ASD is qualitatively distinct
from individuals with AN alone. Given that ARFID rather
than AN per se may be more common in individuals with
ASD, clinicians treating individuals with both an ED and el-
evated ASD symptoms should be mindful of the possibility
that the individual is experiencing a distinct and different ED.
Regardless of the aetiology of ASD symptoms, the pres-
ence of such symptoms in AN has been associated with poorer
treatment outcome and the need for more intensive treatment.
While these symptoms may not be associated with a specific
neurodevelopmental disorder, social and non-social difficul-
ties characteristic of ASD may prevent individuals from en-
gaging in conventional treatments and be associated with oth-
er symptoms such as depression, anxiety or OCD. Screening
for ASD symptoms may therefore be beneficial, although cli-
nicians should be cautious in formally diagnosing ASD with-
out involvement from specialist ASD services. Controlled
studies, comparing treatment response in individuals with
and without ASD symptoms are also needed to determine
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whether specific treatment adaptations or care pathways are
warranted.
Conclusions
Despite differing assessment tools and recruitment from het-
erogeneous patient groups, studies consistently report elevat-
ed ASD symptoms in AN populations. It remains unclear
whether these symptoms represent an underlying
neurodevelopmental disorder, are exacerbated by ED pathol-
ogy or whether they are mere similarities in cognitive and
socioemotional functioning, also shared with other psychiatric
diagnoses. Elevated ASD symptoms are often not corroborat-
ed by developmental history, but until a time when diagnostic
tools account for gender differences in ASD, assessing the
prevalence of ASD in AN will remain difficult. Regardless
of the aetiology of these symptoms, individuals with social
and non-social difficulties characteristic of ASD may require
treatment adaptations or more intensive care. There is a need
for robust longitudinal studies using thorough, gender-specific
ASD assessment methods to further elucidate the relationship
between the two disorders.
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